# A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI

> **NCT05015699** · NA · WITHDRAWN · sponsor: **Sino Medical Sciences Technology Inc.**

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** HT Supreme

## Key facts

- **NCT ID:** NCT05015699
- **Lead sponsor:** Sino Medical Sciences Technology Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09
- **Primary completion:** 2022-09
- **Final completion:** 2025-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn of the research project based on the company's decision
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05015699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05015699, "A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05015699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*